TY - JOUR AU - Palella, F. J. AU - Delaney, K. M. AU - Moorman, A. C. PY - 1998 DA - 1998// TI - Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection JO - N Engl J Med VL - 338 UR - https://doi.org/10.1056/NEJM199803263381301 DO - 10.1056/NEJM199803263381301 ID - Palella1998 ER - TY - STD TI - European AIDS Clinical Society Guidelines 2019. Version 10.0. 2019. https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf. Accessed Nov 2019. UR - https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf ID - ref2 ER - TY - JOUR AU - Montaner, J. S. G. AU - Reiss, P. AU - Cooper, D. PY - 1998 DA - 1998// TI - A randomized, double-blind trial comparing combinations of Nevirapine, Didanosine, and zidovudine for HIV-infected Patients The INCAS trial JO - JAMA VL - 279 UR - https://doi.org/10.1001/jama.279.12.930 DO - 10.1001/jama.279.12.930 ID - Montaner1998 ER - TY - JOUR AU - Friis-Møller, N. AU - Sabin, C. A. AU - Weber, R. PY - 2003 DA - 2003// TI - Combination antiretroviral therapy and the risk of myocardial infarction JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa030218 DO - 10.1056/NEJMoa030218 ID - Friis-Møller2003 ER - TY - JOUR AU - Crum, N. F. AU - Riffenburgh, R. H. AU - Wegner, S. PY - 2006 DA - 2006// TI - Comparisons of causes and death and mortality rates among HIV-infected persons: analysis of the pre-, early and late HAART eras JO - J Acquir Immune Defic Syndr VL - 41 UR - https://doi.org/10.1097/01.qai.0000179459.31562.16 DO - 10.1097/01.qai.0000179459.31562.16 ID - Crum2006 ER - TY - JOUR AU - Carr, A. AU - Cooper, D. A. PY - 2000 DA - 2000// TI - Advrese effects of antiretroviral therapy JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02854-3 DO - 10.1016/S0140-6736(00)02854-3 ID - Carr2000 ER - TY - JOUR AU - Guaraldi, G. AU - Stentarelli, C. AU - Zona, S. PY - 2014 DA - 2014// TI - The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection JO - HIV Med VL - 15 ID - Guaraldi2014 ER - TY - JOUR AU - Dubé, M. P. AU - Shen, C. AU - Greenwald, M. AU - Mather, K. J. PY - 2008 DA - 2008// TI - No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial JO - Clin Infect Dis VL - 47 UR - https://doi.org/10.1086/590154 DO - 10.1086/590154 ID - Dubé2008 ER - TY - JOUR AU - Kamin, D. AU - Hadigan, C. AU - Lehrke, M. AU - Mazza, S. AU - Lazar, M. A. AU - Grinspoon, S. PY - 2005 DA - 2005// TI - Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone JO - J Clin Endocrin Metabol VL - 90 UR - https://doi.org/10.1210/jc.2005-0287 DO - 10.1210/jc.2005-0287 ID - Kamin2005 ER - TY - JOUR AU - Sabin, C. A. AU - Darminio Monforte, A. AU - Friis-Moller, N. PY - 2008 DA - 2008// TI - Changes over time in risk factors for cardiovascular diseases and use of lipid-lowering drugs in HIV infected individuals and impact on myocardial infarction JO - Clin Infect Dis UR - https://doi.org/10.1086/528862 DO - 10.1086/528862 ID - Sabin2008 ER - TY - JOUR AU - Leite, K. M. E. AU - Santos Júnior, G. G. AU - Godoi, E. T. A. M. PY - 2019 DA - 2019// TI - Inflammatory biomarkers and carotid thickness in hiv infected patients under antiretroviraltherapy, undetectable hiv-1 viral load, and low cardiovascular risk JO - Arq Bras Cardiol UR - https://doi.org/10.5935/abc.20190230 DO - 10.5935/abc.20190230 ID - Leite2019 ER - TY - JOUR AU - Phillips, A. N. AU - Carr, A. AU - Neuhaus, J. PY - 2008 DA - 2008// TI - Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial JO - Antivir Ther VL - 13 ID - Phillips2008 ER - TY - JOUR AU - Calza, L. AU - Manfredi, R. AU - Verucchi, G. PY - 2010 DA - 2010// TI - Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis and clinical management JO - AIDS VL - 24 UR - https://doi.org/10.1097/QAD.0b013e328337afdf DO - 10.1097/QAD.0b013e328337afdf ID - Calza2010 ER - TY - JOUR AU - Hazenberg, M. D. AU - Otto, S. A. AU - Benthem, B. H. PY - 2003 DA - 2003// TI - Persistent immune activation in HIV-1 infection is associated with progression to AIDS JO - AIDS VL - 17 UR - https://doi.org/10.1097/00002030-200309050-00006 DO - 10.1097/00002030-200309050-00006 ID - Hazenberg2003 ER - TY - JOUR AU - Brenchley, J. M. AU - Price, D. A. AU - Schacker, T. W. PY - 2006 DA - 2006// TI - Microbial translocation is a cause of systemic immune activation in chronic HIV infection JO - Nat Med VL - 12 UR - https://doi.org/10.1038/nm1511 DO - 10.1038/nm1511 ID - Brenchley2006 ER - TY - JOUR AU - Wada, N. I. AU - Jacobson, L. p. AU - Margolick, J. B. PY - 2015 DA - 2015// TI - The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000545 DO - 10.1097/QAD.0000000000000545 ID - Wada2015 ER - TY - JOUR AU - Comar, M. AU - Zanotta, N. AU - Bonotti, A. PY - 2014 DA - 2014// TI - Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0104848 DO - 10.1371/journal.pone.0104848 ID - Comar2014 ER - TY - JOUR AU - Goff, D. C. AU - Lloyd-Jones, D. M. AU - Bennett, G. PY - 2014 DA - 2014// TI - 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines JO - Circulation VL - 129 UR - https://doi.org/10.1161/01.cir.0000437741.48606.98 DO - 10.1161/01.cir.0000437741.48606.98 ID - Goff2014 ER - TY - JOUR AU - Duffau, P. AU - Ozanne, A. AU - Bonnet, F. PY - 2018 DA - 2018// TI - Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults JO - AIDS VL - 32 UR - https://doi.org/10.1097/QAD.0000000000001875 DO - 10.1097/QAD.0000000000001875 ID - Duffau2018 ER - TY - JOUR AU - Duffau, P. AU - Wittkop, L. AU - Lazaro, E. PY - 2015 DA - 2015// TI - Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV- suppressed patients JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000807 DO - 10.1097/QAD.0000000000000807 ID - Duffau2015 ER - TY - JOUR AU - Islam, F. M. AU - Wu, J. AU - Jansson, J. PY - 2012 DA - 2012// TI - Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta analysis JO - HIV Med UR - https://doi.org/10.1111/j.1468-1293.2012.00996.x DO - 10.1111/j.1468-1293.2012.00996.x ID - Islam2012 ER - TY - JOUR AU - Eyawo, O. AU - Brockman, G. AU - Goldsmith, C. H. PY - 2019 DA - 2019// TI - Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis JO - BMJ Open VL - 9 UR - https://doi.org/10.1136/bmjopen-2018-025874 DO - 10.1136/bmjopen-2018-025874 ID - Eyawo2019 ER - TY - JOUR AU - Feeney, E. R. AU - Mallon, P. W. PY - 2011 DA - 2011// TI - HIV and HAART-associated dyslipidemia JO - TOCMJ VL - 5 UR - https://doi.org/10.2174/1874192401105010049 DO - 10.2174/1874192401105010049 ID - Feeney2011 ER - TY - JOUR AU - Lennox, J. L. AU - Landovitz, R. J. AU - Ribaudo, H. J. AU - Ofotokun, I. AU - Na, L. H. AU - Godfrey, C. PY - 2014 DA - 2014// TI - Efficacy and tolerability of 3 non nucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial JO - Ann InternMed VL - 161 UR - https://doi.org/10.7326/M14-1084 DO - 10.7326/M14-1084 ID - Lennox2014 ER - TY - JOUR AU - Martinez, E. AU - Larrousse, M. AU - Llibre, J. M. AU - Gutierrez, F. AU - Saumoy, M. AU - Antela, A. PY - 2010 DA - 2010// TI - Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study JO - AIDS VL - 24 UR - https://doi.org/10.1097/QAD.0b013e32833a608a DO - 10.1097/QAD.0b013e32833a608a ID - Martinez2010 ER - TY - JOUR AU - Franzese, O. AU - Barbaccia, M. L. AU - Bonmassar, E. AU - Graziani, G. PY - 2018 DA - 2018// TI - Beneficial and detrimental effects of antiretroviral therapy on HIV-associated immunosenescence JO - Chemotherapy VL - 63 UR - https://doi.org/10.1159/000487534 DO - 10.1159/000487534 ID - Franzese2018 ER - TY - JOUR AU - Hileman, C. O. AU - Funderburg, N. T. PY - 2017 DA - 2017// TI - Inflammation, immune activation, and antiretroviral therapy in HIV JO - Curr HIV/AIDS Rep UR - https://doi.org/10.1007/s11904-017-0356-x DO - 10.1007/s11904-017-0356-x ID - Hileman2017 ER - TY - JOUR AU - Patterson, K. B. AU - Prince, H. A. AU - Stevens, T. AU - Shaheen, N. J. AU - Dellon, E. S. AU - Madanick, R. D. PY - 2013 DA - 2013// TI - Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure JO - AIDS VL - 27 UR - https://doi.org/10.1097/QAD.0b013e32835f2b49 DO - 10.1097/QAD.0b013e32835f2b49 ID - Patterson2013 ER - TY - JOUR AU - Jie, L. AU - Xiaowan, Y. AU - Hong, S. AU - Yongjun, J. PY - 2019 DA - 2019// TI - IP-10 is highly involved in HIV infection JO - Cytokine VL - 115 UR - https://doi.org/10.1016/j.cyto.2018.11.018 DO - 10.1016/j.cyto.2018.11.018 ID - Jie2019 ER - TY - JOUR AU - Pinzone, R. AU - Rosa, M. AU - Cacopardo, B. AU - Giuseppe, N. G. PY - 2012 DA - 2012// TI - HIV RNA suppression and immune restoration: can we do better? JO - Clin Dev Immunol VL - 2012 UR - https://doi.org/10.1155/2012/515962 DO - 10.1155/2012/515962 ID - Pinzone2012 ER -